Looking for a specific product?

Make a search for products & suppliers, articles & news.

Collaboration across the pond develops a new living skin equivalent testing model

Epistem and ScandiDerma announced today that they aim to develop a new in vitro human living skin equivalent model for testing inflammatory responses.

Facts

Innovation Norway is the Norwegian Government's most important instrument for innovation and development of Norwegian enterprises and industry. Innovation Norway support companies in developing their competitive advantage and to enhance innovation. Norwegian enterprises have access to a broad business support system as well as financial means. By combining local industry knowledge and international networks with the business ideas and the motivation of entrepreneurs, the foundation for new successful businesses is created. For more information visit www.innovationnorway.com.

Technology Strategy Board is the UK's innovation agency and works to create economic growth by ensuring that the UK is a global leader in innovation. Sponsored by the Department for Business, Innovation and Skills (BIS), the Technology Strategy Board brings together business, research and the public sector, supporting and accelerating the development of innovative products and services to meet market needs, tackle major societal challenges and help build the future economy. For more information please visit www.innovateuk.org.

This is a novel method that will add to the field of dermatological testing as a whole and help create more activity in extracting high value compounds from biomass. The project will last from May 2013 to March 2014 and will run from the project leader Epistem's facilities in Manchester UK and ScandiDerma's facilities in Barents Biocenter, Tromsø, Norway.

"The collaboration with ScandiDerma presents an exciting opportunity to leverage Epistem's strong scientific background in skin biology and inflammation to address the shortage of robust human dermatology models for testing inflammatory responses" said Matthew Walls, Epistem CEO. 

"For ScandiDerma this is an important milestone in building up our competence around test-systems and how to rapidly determine good lead candidates from our bioprospecting activities" noted Ingebjørg Pernille Nedal, CEO ScandiDerma.

The collaboration is made possible through the UK's innovation agency, the Technology Strategy Board, and Innovation Norway following a successful application for funding in the "Sustainable high value chemical manufacture through industrial biotechnology" competition.

(Source: Marketwire)

Associated companies:


Related news

Latest news

The world’s energy demand will peak in 2035 prompting a reshaping of energy investment

The electrification trend is already enveloping the automotive industry.

DNV GL launches revised design standard and new certification guideline for floating wind turbines

The role of offshore wind, including floating offshore wind energy, 

Green Corridor JIP delivers innovative bulk carrier designs for a low emissions future

When the IMO confirmed the 2020 deadline for the 0.5 per cent global sulphur cap in 2016, 

DNV GL launches Operations & Analytics Centre in India to enable 24/7 monitoring for renewable assets globally

The new global monitoring centre is especially significant to independent power providers, 

DNV GL awards AiP to Jiangnan Shipyard for 93K cbm very large ethane carrier design “PANDA E”

The flexible, efficient and environmentally friendly design was developed by Jiangnan Shipyard in cooperation with GTT,

DNV GL starts phase II of project to examine the impact of phase-contamination on oil flow meters

Accurate measurement of the production of oil fields is an important means ...

Important message at the “AKVAculture Day”

We won’t be able to create growth unless we can handle the industry’s challenges.

Visit from the Ministry of Trade Industry and Fisheries

The Ministry visited in order to learn more about the industry. 

Sohome's new 2018 catalogue is out

Sohome has produced a brand new catalogue.